Dr. M.J.D. Grundeken

2024-12-16

Deferral of routine percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation: Rationale and design of the PRO-TAVI trial.

Aarts HM, Hemelrijk KI, Broeze GM, van Ginkel DJ, Versteeg GAA, Overduin DC, Tijssen JG, Beijk MAM, Baan J, Vis MM, Lemkes JS, de Winter RJ, Dickinson MG, Kraaijeveld AO, Mokhles MM, Dessing TC, Grundeken MJ, Claessen BEPM, Tonino PAL, Schotborgh CE, Meuwissen M, van Houwelingen GK, Wykrzykowska JJ, Amoroso G, Vossenberg TN, Vriesendorp PA, van Royen N, Ten Berg JM, Delewi R, Voskuil M.

American heart journal

Edition: 0002-8703 | Pages: 133-139

Lees artikel

2024-08-01

Lipoprotein(a) in interventional cardiology: identifying patients at highest risk of recurrent cardiovascular events through early recognition - a case based review.

Renkens MPL, Coerkamp CF, Witte LS, Sivanesan S, Nurmohamed NS, Westerterp M, Serruys P, Onuma Y, Grundeken MJ, Kalkman DN, Beijk M, Vis MM, Henriques JPS, Delewi R, Stroes E, Wykrzykowska JJ, de Winter RJ, Claessen BEPM.

Expert review of cardiovascular therapy

Edition: 1477-9072 | Pages: 353-366

Lees artikel

2024-07-01

Paclitaxel-coated balloons for vulnerable lipid-rich plaques.

van Veelen A, Küçük IT, Garcia-Garcia HM, Fuentes FH, Kahsay Y, Delewi R, Beijk MAM, den Hartog AW, Grundeken MJ, Vis MM, Henriques JPS, Claessen BEPM.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Edition: 1774-024X | Pages: e826-e830

Lees artikel

2024-05-01

Microplastics and Nanoplastics in Atheromas.

Kalkman DN, Renkens MPL, Grundeken MJ.

The New England journal of medicine

Edition: 0028-4793 | Pages: 1726

Lees artikel

2024-03-04

Correction: van Veelen et al. First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP Study. J. Clin. Med. 2023, 12, 5807.

van Veelen A, Küçük IT, Fuentes FH, Kahsay Y, Garcia-Garcia HM, Delewi R, Beijk MAM, den Hartog AW, Grundeken MJ, Vis MM, Henriques JPS, Claessen BEPM.

Journal of clinical medicine

Edition: 2077-0383 | Pages: 1479

Lees artikel

Dr. M.J.D. Grundeken

Publicaties

Deferral of routine percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation: Rationale and design of the PRO-TAVI trial.

Lipoprotein(a) in interventional cardiology: identifying patients at highest risk of recurrent cardiovascular events through early recognition - a case based review.

Paclitaxel-coated balloons for vulnerable lipid-rich plaques.

Microplastics and Nanoplastics in Atheromas.

Correction: van Veelen et al. First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP Study. J. Clin. Med. 2023, 12, 5807.